Table 1.
Demographic, anthropometric, and clinical characteristics at baseline for the 218 participants who started the 2‐year intervention
| Ad libitum (n = 75) | Caloric restriction (n = 143) | |
|---|---|---|
| N (%) | ||
| Sex | ||
| Female | 53 (70.7) | 99 (69.2) |
| Male | 22 (29.3) | 44 (30.8) |
| Race | ||
| White | 57 (76) | 111 (77.6) |
| African American | 11 (14.7) | 15 (10.5) |
| Other | 7 (9.3) | 17 (11.9) |
| Mean (SD) | ||
|---|---|---|
| Age, year | 37.9 (6.94) | 38.0 (7.34) |
| BMI, kg/m2 | 25.1 (1.64) | 25.2 (1.78) |
| Creatinine, mg/ml | 0.613 (0.224) | 0.720 (0.350) |
| Urinary F2‐isoprostanes, ng/mg creatinine | ||
| Primary measure | ||
| 2,3‐dinor‐iPF(2α)‐III | 1.90 (0.86) | 1.89 (0.81) |
| Secondary measures | ||
| iPF(2α)‐III | 0.211 (0.138) | 0. 209 (0.124) |
| iPF(2α)‐VI | 4.05 (1.55) | 4.12 (1.80) |
| 8,12‐iso‐iPF(2α)‐VI | 5.35 (2.35) | 5.43 (2.41) |
AL, ad libitum control group; CR, 25% caloric restriction group.